Sveriges mest populära poddar
Research To Practice | Oncology Videos
Hälsa och motionMedicin

Multiple Myeloma | What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

47 min•9 oktober 2023

Featuring an interview with Prof Philippe Moreau, including the following topics:

  • Perspectives on efficacy outcomes with and toxicity profiles of daratumumab and isatuximab (0:00)
  • Selection of an anti-CD38 antibody for initial treatment of multiple myeloma (MM) (7:28)
  • Approach to maintenance therapy for transplant-eligible patients with MM (15:47)
  • Management of MM in older patients; treatment approaches for t(11;14) MM (22:47)
  • Management of relapsed/refractory MM (29:49)
  • Management of anti-CD38 antibody-associated side effects (35:45)
  • Other relevant clinical scenarios in MM — Plasma cell leukemia, smoldering myeloma (41:19)
  • Perspectives on the future landscape of up-front treatment for MM (45:02)

CME information and select publications

Fler avsnitt av Research To Practice | Oncology Videos

Visa alla avsnitt av Research To Practice | Oncology Videos
Oral SERDs for Breast Cancer | Erica Mayer, MD, MPH, FASCO
•29 min
Oral SERDs for Breast Cancer | Aditya Bardia, MD, MPH
•28 min
EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
•57 min
EGFR-Mutant Non-Small Cell Lung Cancer | Suresh S Ramalingam, MD
•26 min
EGFR-Mutant Non-Small Cell Lung Cancer | Helena Yu, MD
•30 min
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
•17 min
Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
•58 min
Prostate Cancer | Scott T Tagawa, MD, MS
•25 min
Prostate Cancer | Andrew J Armstrong, MD, ScM
•24 min
Menin Inhibitors in Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
•59 min

Research To Practice | Oncology Videos med Dr Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.